Oncology Brand Commercialization

Resource Allocation

Publication Date	May 2005
Publisher	Cutting Edge Information
Product Type	Report
Pages	287
ISBN Number	not applicable
Product Code	CUT00023

Price

£2,260.00
approximately: $3,292 | €2,608

PDF

PRINT £2,435 ($3,547 | €2,810)

Order above formats by FAX

Summary

Oncology Brand Commercialization: Resource Allocation (PH68)

Use this report's 28 commercial variables to build your own, customized data sets for cancer drug launches.

By combining spending and staffing data from the report's 28 different brand types, you can build resource benchmarks to fit your own unique challenges.

The report's data sets are divided into 10 chapters:

Chapter 1: Drug Class - Explores resources for cytotoxics and innovative therapies
Chapter 2: Market Entrance - Explores resources for first-to-market brands and follow-on/me-too brands
Chapter 3: Indications - Explores resources for brands indicated to treat leukemia, breast cancer, lung cancer, prostate cancer and colorectal cancer
Chapter 4: Peak Sales - Explores resources for brands with projected peak annual sales of more than $1 billion, $500 million to $999 million, and less than $500 million
Chapter 5: Line of Treatment - Explores resources for first-line, second-line and third-line therapeutics
Chapter 6: Clinical Profile - Explores resources for brands with favorable, average, and unfavorable clinical profiles
Chapter 7: Industry Sector - Explores resources for brands commercially supported by major pharmaceutical companies and by biotechnology companies
Chapter 8: Competitive Landscape - Explores resources for brands with strong, average and weak competitive positions
Chapter 9: Promotional Infrastructure - Explores resources for brands with access to strong, average and weak internal resources
Chapter 10: Drug Delivery - Explores resources for brands delivered orally and intravenously

Content

Metrics in The Report
- Oncology Brand Commercialization: Resource Allocation divides averaged brand data into 28 divisions. by picking the data divisions that are most relevant to you, you can build customized oncology data sets to address any number of real or hypothetical marketing situations.
for Each Data Set, The Report Details Resource Levels for 6 Time Periods and 5 Spending Categories.
Time Periods
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Launch
- 12-18 months post-launch
Spending Categories
- Brand total
- Brand activities
- Market research
- Thought leader development
- Advertising
Brand Divisions
Chapter 1: Drug Class
- Cytotoxics
- Innovative therapies
Chapter 2: Market Entrance
- First-to-market brands
- Follow-on/me-too brands
Chapter 3: Indications
- Leukemia
- Breast cancer
- Lung cancer
- Prostate cancer
- Colorectal cancer
Chapter 4: Peak Sales
- Brands with projected peak annual sales of more than $1 billion
- Brands with projected peak annual sales of $500 million to $999 million
- Brands with projected peak annual sales of less than $500 million
Chapter 5: Line of Treatment
- First-line therapeutics
- Second-line therapeutics
- Third-line therapeutics
Chapter 6: Clinical Profile
- Brands with favorable clinical profiles
- Brands with average clinical profiles
- Brands with unfavorable clinical profiles
Chapter 7: Industry Sector
- Brands commercially supported by major pharmaceuticals companies
- Brands commercially supported by biotechnology companies
Chapter 8: Competitive Landscape
- Brands with strong competitive positions
- Brands with average competitive positions
- Brands with weak competitive positions
Chapter 9: Promotional Infrastructure
- Brands with access to strong internal resources
- Brands with access to average internal resources
- Brands with access to weak internal resources
Chapter 10: Drug Delivery
- Brands delivered orally
- Brands delivered intravenously